PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

This study has been terminated.

( Illogistical results found in interim evaluation. )

Study NCT00562198 Information provided by Orion Corporation, Orion Pharma

First Received: November 19, 2007 Last Updated: June 12, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Parkinson´s Disease

Additional conditions recognized in this trial

Parkinson Disease

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Carbidopa
Entacapone
Raclopride
Sinemet

More general drug interventions related to this trial

Sponsors listed in this trial